Gene · 8535
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses. | Mol Cell Proteomics | 2023 | 37730182 | PubTator, text mining | PubMed |
| Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis. | Explor Target Antitumor Ther | 2023 | 37711588 | PubTator, text mining | PubMed |
| Supervised machine learning: A new method to predict the outcomes following exercise intervention in children with autism spectrum disorder. | Int J Clin Health Psychol | 2023 | 37711468 | PubTator, text mining | PubMed |
| Activity Guided Azide-methyllysine Photo-trapping for Substrate Profiling of Lysine Demethylases. | J Am Chem Soc | 2023 | 37703462 | PubTator, text mining | PubMed |
Assessing the Formation of Polycyclic Aromatic Hydrocarbons in Grilled Beef Steak and Beef Patty with Different Charcoals by the Quick, Easy, Cheap, Effective, Rugged, and Safe (QuEChERS) Method with Gas Chromatography-Mass Spectrometry. | Food Sci Anim Resour | 2023 | 37701747 | PubTator, text mining | PubMed |
| CBX4 deletion promotes tumorigenesis under KrasG12D background by inducing genomic instability. | Signal Transduct Target Ther | 2023 | 37696812 | PubTator, text mining | PubMed |
| CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells. | Mol Oncol | 2023 | 37691307 | PubTator, text mining | PubMed |
| Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry. | Transl Oncol | 2023 | 37689006 | PubTator, text mining | PubMed |
| The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids. | Int J Mol Sci | 2023 | 37686244 | PubTator, text mining | PubMed |
| The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review. | Medicine (Baltimore) | 2023 | 37682144 | PubTator, text mining | PubMed |
| aristaless-like homeobox-3 is wound induced and promotes a low-Wnt environment required for planarian head regeneration. | Development | 2023 | 37681295 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in pulmonary diseases. | Mol Med | 2023 | 37670258 | PubTator, text mining | PubMed |
Profiling of primary and phytonutrients in edible mahlab cherry (Prunus mahaleb L.) seeds in the context of its different cultivars and roasting as analyzed using molecular networking and chemometric tools. | PeerJ | 2023 | 37663279 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation. | Mol Ther Nucleic Acids | 2023 | 37655045 | PubTator, text mining | PubMed |
| A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids. | PLoS One | 2023 | 37647325 | PubTator, text mining | PubMed |
| Narrowing the Relationship between Human CCR5 Gene Polymorphisms and Chagas Disease: Systematic Review and Meta-Analysis. | Life (Basel) | 2023 | 37629534 | PubTator, text mining | PubMed |
| Insight into Physiological and Biochemical Determinants of Salt Stress Tolerance in Tetraploid Citrus. | Antioxidants (Basel) | 2023 | 37627635 | PubTator, text mining | PubMed |
| Machine Learning-Based Virtual Screening and Molecular Simulation Approaches Identified Novel Potential Inhibitors for Cancer Therapy. | Biomedicines | 2023 | 37626747 | PubTator, text mining | PubMed |
| The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | Science | 2023 | 37616343 | PubTator, text mining | PubMed |
| Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer. | Cell Commun Signal | 2023 | 37612721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8535/papers?page=10